GLPG2534 is an Orally Active IRAK4 Inhibitor for Inflammatory Skin Diseases Research
Kinases typically integrate signaling events down-stream of multiple cytokine receptors. Hence, kinase inhibitors distinguish themselves from cytokine-targeted biologicals by their capacity to modulate multiple signaling pathways simultaneously. IL-1 receptor (IL-1R)–associated…